RalstonSH, GallacherSJ, PatelU, et al.: Cancer-associated hypercalcaemia: Morbidity and mortality: Clinical experience in 126 treated patients. Ann Intern Med, 1990; 112:499–504.
2.
BodyJJ, LouviausI, DumonJC: Decreased efficacy of bisphosphonates for recurrence of tumor-induced hypercalcaemia. Support Care Cancer, 2000; 8:398–404.
3.
DaveyR, FindlayDM: Calcitonin: Physiology or fantasy?. J Bone Min Res, 2013; 28:973–979.
4.
SekineM, TakamiH: Combination of calcitonin and pamidronate for emergency treatment of malignant hypercalcaemia. Oncol Rep, 1998; 5:197–199.
5.
DiskinCJ, StokesTJ, DansbyLM, et al.: Malignancy-related hypercalcaemia developing on a bisphosphonate but responding to calcitonin. Clin Lung Cancer, 2007; 8:434–435.
